This Tuesday, April 7, 2020 file photo shows a bottle of hydroxychloroquine tablets in Texas City, Texas. The World Health Organization said Monday, May 25, 2020, that it will temporarily drop hydroxychloroquine from its global study into experimental COVID-19 treatments because its experts need to review all available evidence. (David J. Phillip/Associated Press file)

This Tuesday, April 7, 2020 file photo shows a bottle of hydroxychloroquine tablets in Texas City, Texas. The World Health Organization said Monday, May 25, 2020, that it will temporarily drop hydroxychloroquine from its global study into experimental COVID-19 treatments because its experts need to review all available evidence. (David J. Phillip/Associated Press file)

UN virus therapy trial pauses hydroxychloroquine testing

By Maria Cheng and Jamey Keaten | Associated Press

GENEVA — The World Health Organization said Monday that it will temporarily drop hydroxychloroquine — the anti-malarial drug U.S. President Trump says he is taking — from its global study into experimental COVID-19 treatments, saying that its experts need to review all available evidence to date.

In a press briefing, WHO director-general Tedros Adhanom Ghebreyesus said that in light of a paper published last week in the Lancet that showed people taking hydroxychloroquine were at higher risk of death and heart problems, there would be “a temporary pause” on the hydroxychloroquine arm of its global clinical trial.

“This concern relates to the use of hydroxychloroquine and chloroquine in COVID-19,” Tedros said, adding that the drugs are approved treatments for people with malaria or autoimmune diseases. Other treatments in the trial, including the experimental drug remdesivir and an HIV combination therapy, are still being tested.

Tedros said the executive group behind WHO’s global “Solidarity” trial met on Saturday and decided to conduct a comprehensive review of all available data on hydroxychloroquine and that its use in the trial would be suspended for now.

Dr. Michael Ryan, WHO’s emergencies chief, said there was no indication of any safety problems with hydroxychloroquine in the WHO trial to date, but that statisticians would now analyze the information.

“We’re just acting on an abundance of caution based on the recent results of all the studies to to ensure that we can continue safely with that arm of the trial,” he said. WHO said it expected to have more details within the next two weeks.

Last week, Trump announced he was taking hydroxychloroquine although he has not tested positive for COVID-19. His own administration has warned the drug can have deadly side effects, and both the European Medicines Agency and the U.S. Food and Drug Administration warned health professionals last month that the drug should not be used to treat COVID-19 outside of hospital or research settings due to numerous serious side effects that in some cases can be fatal.

Hydroxychloroquine and chloroquine are approved for treating lupus and rheumatoid arthritis and for preventing and treating malaria, but no large rigorous tests have found them safe or effective for preventing or treating COVID-19.

More in News

Rich Foutch of Active Construction, Inc., in Tacoma paints a line on the roadway at the new roundabout at Kearney Street and state Highway 20 for the placement of temporary stripes in a pedestrian crosswalk on Monday in Port Townsend. The temperatures have to be in the mid-50s to install permanent striping, he said. (Steve Mullensky/for Peninsula Daily News)
Roundabout striping

Rich Foutch of Active Construction, Inc., in Tacoma paints a line on… Continue reading

Proposal to rename Sequim road put on hold

Rotary, city to consider other options to honor local Olympian

Researcher: Managed forests needed to fight climate change

Wood products can replace existing fossil fuel-based materials

Jefferson County updates fee schedules

Environmental Public Health up 6 percent

The downtown Port Angeles Christmas tree is surrounded by people during a lighting ceremony on Saturday at First and Lincoln streets. The 30-foot tree will stand at the Conrad Dyar Memorial Fountain plaza through the holidays. (Keith Thorpe/Peninsula Daily News)
Lit up for the holidays

The downtown Port Angeles Christmas tree is surrounded by people during a… Continue reading

tsr
Community Aid seeks support for Toys for Sequim Kids

Nonprofit helps hundreds of children with Christmas presents

Planned electrical outage in Forks on Thursday

A planned power outage in Forks will affect electric service… Continue reading

Nordland man dies of injuries from Nov. 14 wreck

A second person involved in a two-car collision on Nov.… Continue reading

Santa Claus, portrayed by Stephen Rosales of Sequim, waves to the crowd after his arrival by vintage fire truck at Centennial Place in downtown Sequim on Saturday, part of the city’s Hometown Holidays celebration. Santa, accompanied by Irrigation Festival royalty, greeted children next to the city’s Christmas tree in an event that also featured music by the Sequim City Band and a lighted tractor parade. (Keith Thorpe/Peninsula Daily News)
Holiday tradition

Santa Claus, portrayed by Stephen Rosales of Sequim, waves to the crowd… Continue reading

District 3 chief pick bows out

Fire officials could resume search in ’24

Clallam considers law enforcement pact with Makah

The Clallam County commissioners will consider a contract with… Continue reading